Treatment

Displaying 1 - 10 of 199

VNS Therapy receives FDA Approval for MRI labeling

VNS Therapy receives FDA Approval for MRI labeling
LivaNova PLC has announced that its latest VNS Therapy systems (“VNS Therapy”) received FDA approval for expanded MRI labeling, affirming VNS Therapy as the only epilepsy device approved by the FDA for MRI scans. This FDA approval ensures VNS Therapy patients with the latest technology may visit any MRI center in the U.S. and have access to more than 90% of scans routinely performed on patients with epilepsy.
23rd June 2017

Cancer control strategy from African clawed frog unveiled

Cancer control strategy from African clawed frog unveiled
A scientist at Tokyo Institute of Technology has discovered evolutionary fragility of genes encoding cyclin-dependent kinase inhibitors (CDKIs) in African clawed frog (Xenopus), suggesting novel mechanisms suppressing proliferation of cancer cells instead of CDKIs in these species. In their growth and development, all living organisms go through the cell cycle which is controlled by a triad of cyclin-dependent kinases (CDKs), cyclins, and CDK inhibitors (CDKIs).
22nd June 2017

Plastic push-pull connector is suitable for medical applications

Plastic push-pull connector is suitable for medical applications
The SOURIAU's JMX series is a plastic push-pull connector for use in the medical industry, and is designed for easy use by any medical professional. The JMX meets UL 1977 and IEC 60601 standards and connects to surgical devices, diagnostic equipment, and patient monitoring devices. The entire series is available from all SOURIAU distributors in Europe and North America.  
20th June 2017


VR therapy helps decrease pain in hospitalised patients

VR therapy helps decrease pain in hospitalised patients
Virtual reality therapy is effective in significantly reducing pain for hospitalised patients, according to a new Cedars-Sinai study. In the study, published online by JMIR Mental Health, a sister publication of the Journal of Medical Internet Research, investigators examined 100 hospitalised patients who reported pain scores of greater than 3 on the Numeric Pain Rating Scale from zero to 10.
20th June 2017

Coronary dilatation catheters receive FDA Clearance

Coronary dilatation catheters receive FDA Clearance
OrbusNeich has announced the launch of its world-renowned Sapphire PTCA balloon dilatation catheters following their recent 510k clearance by the FDA: the Sapphire II PRO and the Sapphire NC Plus. Specifically engineered for crossing the most difficult lesions and tracking tortuous anatomy, the Sapphire II Pro is tailored for successful dilatation. Its well-balanced sub-zero tapered tip has an ultra-low profile, providing effortless entry through the tightest lesions.
16th June 2017

Photosynthesis could help damaged hearts

Photosynthesis could help damaged hearts
In the ongoing hunt to find better treatments for heart disease, the top cause of death globally, new research from Stanford shows promising results using an unusual strategy: photosynthetic bacteria and light. Researchers found that by injecting a type of bacteria into the hearts of anaesthestised rats with cardiac disease, then using light to trigger photosynthesis, they were able to increase the flow of oxygen and improve heart function, according to a study published in Science Advances.
16th June 2017

Former experimental cancer therapy could treat muscular dystrophy

Former experimental cancer therapy could treat muscular dystrophy
Researchers at the National Institutes of Health's National Center for Advancing Translational Sciences (NCATS) and the University of Nevada, Reno School of Medicine (UNR Med) have demonstrated that a drug originally targeted unsuccessfully to treat cancer may have new life as a potential treatment for Duchenne muscular dystrophy (DMD). The candidate drug, SU9516, represents a different kind of approach for treating DMD, a degenerative muscle disease that usually begins in childhood and has no known cure.
14th June 2017

Tech to drive next-gen therapies for MS

Tech to drive next-gen therapies for MS
Researchers in the University of Maryland (UMD) Fischell Department of Bioengineering (BIOE) Jewell Laboratory are using quantum dots to decipher the features needed to design specific and effective therapies for multiple sclerosis (MS) and other autoimmune diseases. Their findings were published as the cover story of Advanced Functional Materials.
14th June 2017

Ultrasound 'drill' targets deep vein blood clots

Ultrasound 'drill' targets deep vein blood clots
Researchers at North Carolina State University and the University of North Carolina at Chapel Hill have developed a new surgical tool that uses low-frequency intravascular ultrasound to break down blood clots that cause deep vein thrombosis. The tool is the first ultrasound 'drill' that can be aimed straight ahead, allowing doctors to better target clots—which holds promise for significantly reducing treatment time. To date, the technology has been tested only in synthetic blood vessels.
14th June 2017

Phagocytic protocells could targeted delivery of enzymes

Phagocytic protocells could targeted delivery of enzymes
Researchers at the University of Bristol have designed a community of artificial cell-like droplets that collectively displays a simple form of phagocytosis behaviour. The work provides an approach to designing complex life-like properties in non-living materials. The chemists have made a major advance in the construction of synthetic communities of artificial cells capable of mimicking phagocytosis—a complex biological process seen in living cells that enables the ingestion of foreign material by certain cell types.
13th June 2017


Treatment documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

EPE 2017 ECCE Europe
11th September 2017
Poland Warsaw
DSEI 2017
12th September 2017
United Kingdom ExCeL, London
RWM 2017
12th September 2017
United Kingdom NEC, Birmingham
Productronica India 2017
14th September 2017
India Pragati Maidan, New Delhi
Industry of Things World 2017
18th September 2017
Germany Berlin Congress Center